文献速递炎症性肠病

急性重症溃疡性结肠炎患者第7天直肠出血缓解可预测出院后无激素临床缓解及内镜改善

Resolution of Rectal Bleeding by Day 7 in Acute Severe Ulcerative Colitis Is Prognostic for Postdischarge Corticosteroid-Free Clinical Remission and Endoscopic Improvement.
PubMed 文献 · Am J Gastroenterol · 2024-05-08

本研究为TRIUMPH试验的事后分析,评估改良Truelove Witts严重指数与部分Mayo评分对住院急性重症溃疡性结肠炎患者出院后无激素临床缓解及内镜改善的预测价值。结果提示Mayo直肠出血子评分缓解可能具有高预后价值,可考虑作为住院UC试验的主要终点。

要点

  • 第7天Mayo直肠出血子评分缓解可能预测出院后无激素临床缓解及内镜改善。
  • Mayo直肠出血子评分缓解可考虑作为住院UC试验的主要终点。
  • 需在更大规模人群中进一步研究患者报告结局及内镜指数。

核心结论

  • Mayo直肠出血子评分缓解可能具有高预后价值,可考虑作为住院UC试验的主要终点。

研究设计与样本

  • TRIUMPH试验的事后分析,评估改良Truelove Witts严重指数与部分Mayo评分在住院急性重症溃疡性结肠炎患者中的预测价值。

主要发现

  • 第7天Mayo直肠出血子评分缓解可能预测出院后无激素临床缓解及内镜改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study assesses 2 different disease activity measures, the Modified Truelove Witts Severity Index and the partial Mayo score, in hospitalized patients with acute severe ulcerative colitis (UC) for prediction of postdischarge corticosteroid-free clinical remission and endoscopic improvement to help guide future considerations for disease activity assessment. In this post hoc analysis from the Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (TRIUMPH) trial, these results suggest resolution of the Mayo rectal bleeding subscore may have high prognostic utility and could be considered as a primary end point for hospitalized UC trials. The study underscores the need for further research on patient-reported outcomes and endoscopic indices in larger populations for inpatient UC trials.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Narula N, Hamam H, Peerani F, et al. Resolution of Rectal Bleeding by Day 7 in Acute Severe Ulcerative Colitis Is Prognostic for Postdischarge Corticosteroid-Free Clinical Remission and Endoscopic Improvement. Am J Gastroenterol. 2024. PMID: 38775974. doi:10.14309/ajg.0000000000002860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。